{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:57:04Z","timestamp":1792792624054,"version":"4.5.0"},"reference-count":99,"publisher":"Informa UK Limited","issue":"1","funder":[{"name":"by National Multiple Society Sylvia Lawry Physician Fellowship","award":["FP-1506-04742"],"award-info":[{"award-number":["FP-1506-04742"]}]},{"name":"National Multiple Sclerosis Society Institutional Clinician Training Award","award":["ICT 0002"],"award-info":[{"award-number":["ICT 0002"]}],"id":[{"id":"https:\/\/ror.org\/03019wv17","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2017,1,2]]},"DOI":"10.1080\/14740338.2017.1250881","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T04:10:05Z","timestamp":1476850205000},"page":"89-100","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":36,"title":["Safety of monoclonal antibodies for the treatment of multiple sclerosis"],"prefix":"10.1080","volume":"16","author":[{"given":"Marisa P.","family":"McGinley","sequence":"first","affiliation":[{"name":"Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon P.","family":"Moss","sequence":"additional","affiliation":[{"name":"Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,10,31]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002469"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000768"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200009283431307"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2006.09.011"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1038\/256495a0"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70110-8"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2399"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.3537"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1038\/356063a0"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20859"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000327671.91357.96"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.12.noc80051"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044397"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044396"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007621.pub2"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000343880.13764.69"},{"key":"CIT0017","volume-title":"Presented at the 2016 Annual Meeting of the American Academy of Neurology","author":"Steiner D"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000277457.17420.b5"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051847"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051782"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051586"},{"key":"CIT0022","unstructured":"Biogen. Tysabri (natalizumab): PML in Patients Receiving Tysabri, [cited 2016 Jun 23]. http:\/\/medinfo.biogen.com. Accessed 14 Aug 2016."},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107829"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24286"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70028-4"},{"issue":"2","key":"CIT0026","first-page":"117","volume":"87","author":"McGuigan C","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-015-7655-1"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-312940"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512439438"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31828c2fa1"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.01.010"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit376"},{"key":"CIT0033","unstructured":"Biogen. Tysabri prescribing information, revised 05\/2016. Available at: https:\/\/www.tysabri.com\/content\/dam\/commercial\/multiple-sclerosis\/tysabri\/pat\/en_us\/pdfs\/tysabri_prescribing_information.pdf. [cited 2016 Aug 06]."},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5200-9"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2013.10.018"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-012-0967-7"},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1365-2036.2010.04262.x","volume":"31","author":"Bezabeh S","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000355"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv260"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001706"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24651"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.209"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514546790"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c97ed3"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1998.00472.x"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2009.03115.x"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535075"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0556-9"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-009-9327-3"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61769-3"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61768-1"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70020-5"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/119.1.225"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802670"},{"issue":"9191","key":"CIT0055","first-page":"1691","volume":"354","author":"Aj C","year":"1995","journal-title":"Lancet"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1177\/1756285614563522"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-371138"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0800484"},{"key":"CIT0059","unstructured":"Genzyme\/Sanofi. Lemtrada Prescribing Information, revised 11\/2014. Available from: http:\/\/products.sanofi.us\/Lemtrada\/Lemtrada.pdf. [cited 2016 Aug 06]."},{"issue":"1","key":"CIT0060","first-page":"S247","volume":"15","author":"Wray S","year":"2009","journal-title":"Mult Scler J"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160714669"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.0146"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514554053"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0601335103"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62190-4"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70039-0"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501481"},{"key":"CIT0068","unstructured":"Biogen\/Abbvie. Zinbryta prescribing information, revised 05\/2016. Available at: https:\/\/www.zinbryta.com\/content\/dam\/commercial\/multiple-sclerosis\/zinbryta\/na\/en_us\/pdfs\/zinbryta-prescribing-information.pdf. [cited Aug 2016 06]."},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1177\/1352458508097468"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0402653101"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000267662.41734.1f"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.16"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-016-0048-2"},{"issue":"4","key":"CIT0074","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.4049\/jimmunol.125.4.1678","volume":"125","author":"Stashenko P","year":"1980","journal-title":"J Immunol"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp0708143"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706383"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21867"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21363"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181e24373"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1186\/ar3337"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2010.01.002"},{"key":"CIT0082","unstructured":"Food and Drug Administration Safety Warning. 2013 Sep 25. Boxed Warning and new recommendations to decrease risk of hepatitis B reactivation with the immune-suppressing and anti-cancer drugs Arzerra (ofatumumab) and Rituxan (rituximab). Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm366406.htm. [cited 2016 Jul 25]."},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-186999"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.103"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0098"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-15-178"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker106a"},{"key":"CIT0088","unstructured":"Genentech. Rituxan prescribing information, revised 04\/2016. Available at: http:\/\/www.gene.com\/download\/pdf\/rituxan_prescribing.pdf. [cited Aug 2016 06]."},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-295444"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq027"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70192-3"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61649-8"},{"issue":"11","key":"CIT0093","first-page":"61","volume":"21","author":"Hauser SL","year":"2015","journal-title":"Mult Scler J"},{"issue":"11","key":"CIT0094","first-page":"780","volume":"23","author":"Montalban X","year":"2015","journal-title":"Mult Scler J"},{"key":"CIT0095","unstructured":"Roche Press Release 2010 Mar 08 . Roche and Biogen Idec decide to suspend ocrelizumab treatment - rheumatoid arthritis development programme on hold. Available at: http:\/\/www.roche.com\/media\/store\/releases\/med-cor-2010-03-08.htm. [cited 2016 Jul 25]."},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000125"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70028-6"},{"issue":"3","key":"CIT0099","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1212\/NXI.0000000000000235","volume":"3","author":"Major EO","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2017.1250881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T21:23:41Z","timestamp":1718832221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2017.1250881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,31]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1,2]]}},"alternative-id":["10.1080\/14740338.2017.1250881"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2017.1250881","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,31]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-08-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-10-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-10-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}